Alerts will be sent to your verified email
Verify EmailZENITHDRUG
|
Zenith Drugs
|
Bharat Immunological
|
Bacil Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.81 % | 0.0 | 0.32 % |
|
5yr average Equity Multiplier
|
3.92 | 3.08 | 1.36 |
|
5yr Average Asset Turnover Ratio
|
1.08 | 0.61 | 0.0 |
|
5yr Avg Net Profit Margin
|
5.08 % | -18.38 % | 0.0 |
|
Price to Book
|
1.01 | 0.89 | 2.66 |
|
P/E
|
9.82 | 0.0 | 94.39 |
|
5yr Avg Cash Conversion Cycle
|
-5.9 Days | 206.63 Days | 0.0 |
|
Inventory Days
|
59.46 Days | 125.06 Days | 0.0 |
|
Days Receivable
|
153.74 Days | 61.4 Days | 0.0 |
|
Days Payable
|
283.33 Days | 117.81 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
3.87 | -2.32 | -943.72 |
|
5yr Avg ROCE
|
26.61 % | -44.64 % | -75.56 % |
|
5yr Avg Operating Profit Margin
|
9.63 % | -18.7 % | 0.0 |
|
5 yr average Debt to Equity
|
1.03 | 0.71 | 0.05 |
|
5yr CAGR Net Profit
|
17.92 % | 23.51 % | n/a |
|
5yr Average Return on Assets
|
5.28 % | -10.1 % | -70.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.98 % | 59.25 % | 0.08 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -42.59 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zenith Drugs
|
Bharat Immunological
|
Bacil Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|